The PPARα pathway was enriched for placental genes impacted by obesity, and PPARα antagonism significantly reduced 3H-palmitate oxidation in 1st trimester placental explants. The gene discussed is PPARA; the disease is obesity due to melanocortin 4 receptor deficiency.